| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Paclitaxel/Hyaluronic acid | Phase 3 Clinical | Fidia Pharma | Carcinoma, Papillary; Urinary Bladder Neoplasms | 詳細 | |
| CA-102N | CA-102N | Phase 2 Clinical | Holy Stone Healthcare Co Ltd | Colorectal Neoplasms; Solid tumours | 詳細 |
| P-134 | P-134; P134 | Phase 2 Clinical | Tianjin Tasly Pharmaceutical Co Ltd | Glioblastoma | 詳細 |
| Rosuvastatin liposome encapsulated therapy (Beijing Inno Medicine) | YN001; YN-001 | Phase 2 Clinical | Beijing Inno Medicine Co Ltd | Atherosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Erectile Dysfunction | 詳細 |
| AMT-116(Multitude Therapeutics) | AMT-116; AMT-116-ADC | Phase 2 Clinical | Multitude Therapeutics Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Head and Neck Neoplasms; Solid tumours | 詳細 |
| Hyaluronic acid/Fluorouracil | HA-5FU; HA-5-fluorouracil; Hyaluronic acid-5-fluorouracil complex; Hyaluronan acid-5-fluorouracil complex | Phase 2 Clinical | Alchemia Ltd, Monash University | Colorectal Neoplasms | 詳細 |
| AMC-303 | AMC-303; HP-558 | Phase 1 Clinical | Amcure Gmbh | Esophageal Squamous Cell Carcinoma; Solid tumours | 詳細 |
| Clodronic acid/Hyaluronic acid | Phase 1 Clinical | Abiogen Pharma Spa | Osteoarthritis | 詳細 | |
| 177Lu-AKIR001 | 177Lu-AKIR001 | Phase 1 Clinical | Akiram Therapeutics AB | Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Neoplasms; Thyroid Carcinoma, Anaplastic; Uterine Cervical Neoplasms; Vulvar Neoplasms | 詳細 |
| BGC-0228 | BGC-0228 | Phase 1 Clinical | Brightgene Bio-Medical Technology Co Ltd | Solid tumours | 詳細 |